HYMOVIS

DEVICE3 trials

Sponsors

Fidia Farmaceutici s.p.a., National Jewish Health

Conditions

Knee Osteoarthritis

Unknown Phase

Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

Fidia Farmaceutici s.p.a.Knee Osteoarthritis

Start: 2014-06-30End: 2016-03-31Target: 332Updated: 2015-10-05

Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection

National Jewish HealthKnee Osteoarthritis

Start: 2019-01-01End: 2022-02-01Target: 50Updated: 2021-03-03

Evaluation of the Evolution of Biological and Imaging Markers of Bone and Cartilage Degradation in Patients With Knee Osteoarthritis Receiving Intra-articular Injections of a Hyaluronan Derivative HYMOVIS®

CompletedNCT04293861

Fidia Farmaceutici s.p.a.Knee Osteoarthritis

Start: 2015-04-01End: 2017-06-06Updated: 2020-03-06